Skip to content
← Back to this collection

PUBLICATIONS · 20668473

Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Leukemia
Publication date
2010 Sep
First author
van der Velden VH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      van der Velden VH
      type
      Author
    2. name
      van der Sluijs-Geling A
      type
      Author
    3. name
      Gibson BE
      type
      Author
    4. name
      te Marvelde JG
      type
      Author
    5. name
      Hoogeveen PG
      type
      Author
    6. name
      Hop WC
      type
      Author
    7. name
      Wheatley K
      type
      Author
    8. name
      Bierings MB
      type
      Author
    9. name
      Schuurhuis GJ
      type
      Author
    10. name
      de Graaf SS
      type
      Author
    11. name
      van Wering ER
      type
      Author
    12. name
      van Dongen JJ
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      van der Velden VH
      type
      Author
    2. name
      van der Sluijs-Geling A
      type
      Author
    3. name
      Gibson BE
      type
      Author
    4. name
      te Marvelde JG
      type
      Author
    5. name
      Hoogeveen PG
      type
      Author
    6. name
      Hop WC
      type
      Author
    7. name
      Wheatley K
      type
      Author
    8. name
      Bierings MB
      type
      Author
    9. name
      Schuurhuis GJ
      type
      Author
    10. name
      de Graaf SS
      type
      Author
    11. name
      van Wering ER
      type
      Author
    12. name
      van Dongen JJ
      type
      Author
    bibliography ids
    1. nci-bib-7eed39f4bb184f92a3e5a683
    book metadata
    content sha256
    f37d85d379849c22dc15696a673e63cadc85cbf46d25b2b5ef8783fdc4a244c3
    document type
    citation
    dois
    1. 10.1038/leu.2010.153
    electronic publication date
    display
    2010 Jul 29
    precision
    day
    year
    2010
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:20668473
    immutable id
    pubmed:20668473@f37d85d379849c22dc15696a673e63cadc85cbf46d25b2b5ef8783fdc4a244c3
    journal
    abbreviation
    Leukemia
    issn electronic
    1476-5551
    issn print
    0887-6924
    issue
    9
    name
    Leukemia
    nlm unique id
    8704895
    pages
    1599-606
    volume
    24
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      20668473
      provenance
      batch id
      10a38257e12e9ed1867a
      provider
      NCBI PubMed ESummary
      record sha256
      e7ae688bd60b81953c70fc9df1a94bcf770b2a7f9042779abae27c0413a4c79a
      response sha256
      84c4808ca38b35d999cfdf809eb088835175ab38d71586c626096d677096bbcc
      retrieved at
      2026-09-09T23:46:35.793530+00:00
      publication date
      display
      2010 Sep
      precision
      month
      year
      2010
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/20668473/
      title
      Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol.

      Preserved source evidence · Not medical advice